Chenli Liu

Chenli Liu is a Pengcheng Distinguished Professor and President of Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, the Founding Directors of State Key Laboratory for Quantitative Synthetic Biology, National Industrial Innovation Center for Biomanufacturing (NIICB), and Shenzhen Institute of Synthetic Biology (iSynBio), the Chief Scientist of Shenzhen Infrastructure for Synthetic Biology, the Chief Scientist of Chinese Academy of Sciences Synthetic Cell Initiative, and National Natural Science Foundation of China Basic Science Center on Synthetic Cell, the co-founder and coordinator of SynCell Asia Initiative. He also co-founded the Global Biofoundry Alliance (GBA) and the Asian Synthetic Biology Association (ASBA). Liu also serves as the Executive Editor-in-Chief of Synthetic Biology Journal (Chinese), Associate Editors of Engineering Biology, and mLife, and as Editorial Advisory Board member of the journals ACS Synthetic Biology, Systems and Synthetic Biotechnology, Quantitative Biology, and Journal of Genetics and Genomics.

Liu obtained his Ph.D in Biochemistry from the University of Hong Kong, and postdoctoral training at MCB, Harvard University. Liu started his lab at SIAT in 2014. Liu lab is focused on bringing together concepts and approaches from synthetic biology together with quantitative biology. Current research interest includes synthesizing a cellular life from bottom up and engineering bacteria for solid tumor therapy.

He is the recipients of several prestigious awards, e.g. "Agilent Thought Leader Award", "C.C. Tan Life Science Innovation Award", "Young Scientists Award of the Chinese Academy of Sciences", "VCANBIO Award for Biosciences and Medicine", "Li Ka Shing Award", "Hong Kong Young Scientist Award".